| 000 | 01781 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516002159.0 | ||
| 264 | 0 | _c20110726 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1600-0447 | ||
| 024 | 7 |
_a10.1111/j.1600-0447.2010.01599.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchueler, Y-B | |
| 245 | 0 | 0 |
_aA systematic review of duloxetine and venlafaxine in major depression, including unpublished data. _h[electronic resource] |
| 260 |
_bActa psychiatrica Scandinavica _cApr 2011 |
||
| 300 |
_a247-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntidepressive Agents, Second-Generation _xpharmacokinetics |
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xpharmacokinetics |
| 650 | 0 | 4 |
_aCyclohexanols _xpharmacokinetics |
| 650 | 0 | 4 |
_aDepressive Disorder, Major _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDuloxetine Hydrochloride |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPharmacological Phenomena |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 |
_aThiophenes _xpharmacokinetics |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aVenlafaxine Hydrochloride |
| 700 | 1 | _aKoesters, M | |
| 700 | 1 | _aWieseler, B | |
| 700 | 1 | _aGrouven, U | |
| 700 | 1 | _aKromp, M | |
| 700 | 1 | _aKerekes, M F | |
| 700 | 1 | _aKreis, J | |
| 700 | 1 | _aKaiser, T | |
| 700 | 1 | _aBecker, T | |
| 700 | 1 | _aWeinmann, S | |
| 773 | 0 |
_tActa psychiatrica Scandinavica _gvol. 123 _gno. 4 _gp. 247-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0447.2010.01599.x _zAvailable from publisher's website |
| 999 |
_c20163794 _d20163794 |
||